Theleme Partners LLP Portfolio
Auto-discovered 13F filer (Top-2000 by latest reported value).
SEC 13F CIK: 0001511881
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Q3 2026 · 10 positions · Total reported value $2.62B · Top-10 concentration 100.0% · Updated 2026-11-14
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
Turnover: 30.0% · 1 new · 2 cut · 0 exited
Active Share (vs S&P 500): 87.6% · vs QQQ: 86.9% — share of the book that differs from index weights (higher = more active) · ranking
In its Q3 2026 13F filing, Theleme Partners LLP disclosed 10 equity positions with a combined reported value of $2.62B. The filing implies a focused portfolio: its ten largest positions account for 100.0% of reported value. HoldingsHub classifies the profile as Mid / Focused / Health Tilt / High Turnover.
The largest disclosed positions as of Q3 2026 were MRNA ($1.28B), META ($286.64M), AMZN ($227.38M). By sector, the heaviest allocations are Health Care 48.9%, Technology 18.7%. Versus the prior quarter, allocation shifted toward Health Care (+15.4pp), Technology (+2.0pp) and away from Real Estate (-2.5pp), Financials (-6.6pp).
Versus the prior quarter, Theleme Partners LLP opened 1 new positions, trimmed 2 and fully exited 0, a turnover rate of 30.0% of positions. The portfolio's overlap with the prior quarter was 90% of names.
The largest new positions opened in Q3 2026 were MSFT ($185.43M).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
New Positions (Q3 2026)
- MSFT MICROSOFT CORP · $185.43M
Fully Exited (vs previous quarter)
No tracked position was fully exited this quarter.
Insider Transactions (Form 4)
Latest Theleme Partners LLP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.
Fund Profile
Theleme Partners LLP is an SEC-registered 13F filer. As of Q2 2026 it reported 9 US equity positions with a combined value of $1.68B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).
Portfolio Structure
- 9 positions · $1.68B reported value (Q2 2026)
- Top 10 holdings = 100.0% of reported value
- Largest position: MRNA (MODERNA INC) at 33.5%
- Average position size: $187.05M
Sector Tilt
- Health Care 33.5%
- Consumer Discretionary 25.4%
- Financials 18.0%
- (classified holdings cover 100% of value)
Quarterly Activity
- Q2 2026: 2 new, 4 added, 2 exited
- 3 positions unchanged
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
Sector Allocation
| # | Company | Shares | Value | Weight | Allocation | Change |
|---|---|---|---|---|---|---|
| 1 |
|
6.66M | $1.28B | 48.90% | Reduce | |
| 2 |
|
395.27K | $286.64M | 10.93% | Reduce | |
| 3 |
|
912.63K | $227.38M | 8.67% | Add | |
| 4 |
|
3.20M | $219.00M | 8.35% | Hold | |
| 5 |
|
361.53K | $185.43M | 7.07% | New | |
| 6 |
|
2.37M | $144.84M | 5.53% | Hold | |
| 7 |
|
105.60K | $106.83M | 4.08% | Hold | |
| 8 |
|
616.21K | $84.57M | 3.23% | Add | |
| 9 |
|
3.04M | $67.84M | 2.59% | Add | |
| 10 |
|
1.28M | $17.04M | 0.65% | Hold |
FAQ
What did Theleme Partners LLP buy in 2026-Q3?
In its 2026-Q3 13F filing, Theleme Partners LLP reported 10 equity positions worth $2.62B in aggregate; its largest disclosed positions were MRNA ($1.28B), META ($286.64M), AMZN ($227.38M).
How large is Theleme Partners LLP's portfolio?
Theleme Partners LLP reported $2.62B of long equity holdings across 10 positions as of 2026-Q3. Top-10 holdings account for 100.0% of reported value.
What is Theleme Partners LLP's investment style?
HoldingsHub classifies the portfolio as Mid / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.